Home  |  Careers  |  Contact Us  |  Sitemap
About
Getz Pharma
  Research &
Development
  Business
Partnerships
  Marketing &
Sales
  Technical
Operations
  Products   Getz Pharma Cares

Back

Fenofibrate

Country:  

Therapeutic Segment

Anti-lipidemic

Generic Name

Fenofibrate

Indication

It is indicated as adjunctive therapy to diet for the reduction of LDL-C, Total-C, Triglycerides and Apo B in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Type IIa and IIb). Fenoget is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia (Fredrickson types IV and V hyperlipidemia).


Brands

Fenoget
Fenogetz

Form

Capsules

(Hover on images to enlarge)

Home :  Legal
©2014 Getz Pharma (Pvt) Ltd.

Site Powered by USFI